107 related articles for article (PubMed ID: 7485095)
41. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
Lazzarino M; Orlandi E; Klersy C; Astori C; Brusamolino E; Corso A; Bellio L; Gargantini L; Morra E; Bernasconi C
Cancer; 1998 Feb; 82(3):576-82. PubMed ID: 9452277
[TBL] [Abstract][Full Text] [Related]
42. Usefulness of laparoscopy with liver biopsy in the assessment of liver involvement at diagnosis of Hodgkin's and non-Hodgkin's lymphomas.
Sans M; Andreu V; Bordas JM; Llach J; López-Guillermo A; Cervantes F; Bruguera M; Mondelo F; Montserrat E; Terés J; Rodés J
Gastrointest Endosc; 1998 May; 47(5):391-5. PubMed ID: 9609433
[TBL] [Abstract][Full Text] [Related]
43. Antibody response to adenovirus E1b-derived synthetic peptides and serum levels of p53 in patients with gastrointestinal and other malignant lymphomas.
Lähdeaho ML; Lehtinen T; Aine R; Hakala T; Lehtinen M
J Med Virol; 1994 Aug; 43(4):393-6. PubMed ID: 7964649
[TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of TNF alpha and its p55 soluble receptor in malignant lymphomas.
Warzocha K; Salles G; Bienvenu J; Barbier Y; Bastion Y; Doche C; Rieux C; Coiffier B
Leukemia; 1997 Apr; 11 Suppl 3():441-3. PubMed ID: 9209418
[TBL] [Abstract][Full Text] [Related]
45. Parathyroid-hormone-related peptide in hematologic malignancies.
Kremer R; Shustik C; Tabak T; Papavasiliou V; Goltzman D
Am J Med; 1996 Apr; 100(4):406-11. PubMed ID: 8610726
[TBL] [Abstract][Full Text] [Related]
46. Serum trace elements and Cu/Zn ratio in malignant lymphomas in children.
Gupta SK; Shukla VK; Gupta V; Gupta S
J Trop Pediatr; 1994 Jun; 40(3):185-7. PubMed ID: 8078119
[TBL] [Abstract][Full Text] [Related]
47. Malignant lymphoma in western Ethiopia.
Getachew A
East Afr Med J; 2001 Aug; 78(8):402-4. PubMed ID: 11921560
[TBL] [Abstract][Full Text] [Related]
48. The malignant lymphomas of Kenya: morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases.
Cool CD; Bitter MA
Hum Pathol; 1997 Sep; 28(9):1026-33. PubMed ID: 9308726
[TBL] [Abstract][Full Text] [Related]
49. Superoxide anion (O-2) production by peripheral blood monocytes in Hodgkin's disease and malignant lymphoma.
Perez-Soler R; Lopez-Berestein G; Cabanillas F; McLaughlin P; Hersh EM
J Clin Oncol; 1985 May; 3(5):641-5. PubMed ID: 2987422
[TBL] [Abstract][Full Text] [Related]
50. Increased immunoglobulin E and interferon-gamma in patients with malignant lymphoma.
Melichar B; Krejsek J; Drahosova M; Jebavy L; Siroky O; Blaha M; Maly J
Acta Haematol; 1995; 94(3):167-8. PubMed ID: 7502637
[No Abstract] [Full Text] [Related]
51. The significance of serum levels of soluble 60kDa receptors for tumor necrosis factor in patients with Hodgkin's disease.
Gruss HJ; Dölken G; Brach MA; Mertelsmann R; Herrmann F
Leukemia; 1993 Sep; 7(9):1339-43. PubMed ID: 8396696
[TBL] [Abstract][Full Text] [Related]
52. Pregnancy-associated alpha 2-glycoprotein in children with acute lymphocytic leukemia, Hodgkin's disease and non-Hodgkin's lymphomas.
Zalazar FE; Chiabrando GA; de Aldao NA; Ojeda F; Vides MA; Aldao MA
Clin Chim Acta; 1992 Sep; 210(1-2):133-8. PubMed ID: 1424154
[No Abstract] [Full Text] [Related]
53. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
[TBL] [Abstract][Full Text] [Related]
54. Prothrombotic hemostatic abnormalities in patients with refractory malignant lymphoma presenting for autologous stem cell transplantation.
Conlan MG; Haire WD; Kessinger A; Armitage JO
Bone Marrow Transplant; 1991 Jun; 7(6):475-9. PubMed ID: 1873594
[TBL] [Abstract][Full Text] [Related]
55. Elevated polyamine content in erythrocytes of malignant lymphoma patients.
Uehara N; Kita K; Shirakawa S; Uchino H; Saeki Y
Gan; 1980 Jun; 71(3):393-7. PubMed ID: 6998825
[TBL] [Abstract][Full Text] [Related]
56. Clinical significance of the serum IL-2R level and Ga-67 scan findings in making a differential diagnosis between sarcoidosis and non-Hodgkin's lymphoma.
Kita T; Watanabe S; Yano F; Hayashi K; Yamamoto M; Iwasaki Y; Kosuda S
Ann Nucl Med; 2007 Nov; 21(9):499-503. PubMed ID: 18030581
[TBL] [Abstract][Full Text] [Related]
57. One question on the work on antinuclear antibody levels in patients with Hodgkin's and non-Hodgkin's lymphoma.
Berrutti M; Pellicano R; Rizzetto M
Minerva Med; 2008 Aug; 99(4):417. PubMed ID: 18663350
[No Abstract] [Full Text] [Related]
58. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of soluble CD44 in patients with breast and colorectal carcinomas and non-Hodgkin's lymphoma.
Lockhart MS; Waldner C; Mongini C; Gravisaco MJ; Casanova S; Alvarez E; Hajos S
Oncol Rep; 1999; 6(5):1129-33. PubMed ID: 10425314
[TBL] [Abstract][Full Text] [Related]
60. Serum levels of ceruloplasmin, properdin factor B and copper in lymphoma patients.
Casamassima A; Addabbo L; Caporusso L; Lorusso V
Int J Biol Markers; 1991; 6(3):183-7. PubMed ID: 1791312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
